Our AllergyWise® for Schools training programme has just got even better!  Not only has it been written and designed by educators and is evidence based and reviewed by our leading clinical and scientific panel including allergy consultants… We’re delighted to share it is now CPD certified by the CPD certification service. 

A study of 61 Irish primary school teachers published in the European Journal of Pediatrics this April has found low levels of competence and confidence in adrenaline auto-injector (AAIs) use.

Anaphylaxis UK is proud to be recognising our 30th anniversary this year… Three decades of unwavering support. To mark the anniversary, we’re launching our ’30 Reasons’ anniversary campaign to showcase the people and stories that motivate us to do what we do here at Anaphylaxis UK.

Well done to Benedict Blythe Foundation for publishing their REACT report on the subject of allergies in schools.

We’re thrilled to announce that we are partnering with ITN Business to produce an upcoming news-style programme ‘Allergy Aware’, launching on 1st October to coincide with Anaphylaxis Awareness Week.

We’re delighted to welcome Tracey Dunn to the Anaphylaxis UK Team as our Education and AllergyWise Manager.

The Benedict Blythe Foundation has published an Action Paper detailing recommendations for schools to help keep pupils with allergies safe. Five-year-old Benedict Blythe died of anaphylaxis on 1st December 2021 after collapsing at school. His parents have spent the last

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued clarification on when schools’ spare adrenaline auto-injectors can be used.

Pharmaswiss Česka republika s.r.o. and distributor Bausch & Lomb UK Limited is recalling all unexpired batches of Emerade 300 and Emerade 500 micrograms adrenaline auto-injectors.